{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:03:55Z","timestamp":1783634635012,"version":"3.55.0"},"reference-count":212,"publisher":"Bioscientifica","issue":"3","content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Angiogenesis is a key event, which occurs in both normal and pathological expansion of tissues and provides the nourishment necessary for growth. The role of angiogenic growth factors in breast pathology is rapidly gaining recognition since scientists and clinicians realized that these factors could function as molecular targets event 550 209822 for controlling tumor expansion. Vascular endothelial growth factor (VEGF) is a key regulator of angiogenesis. Although significant advances have been made in understanding the sex-steroid-dependent regulation of this key factor, the role of VEGF in controlling breast tumors is not well understood. In this review, I discuss recent studies describing the role of the female sex steroids estrogens and progestins in the regulation of VEGF in breast cancer cells. Furthermore, I present a summary of recent studies from other biological systems (mainly focused on tumor biology) directed towards providing us with a better understanding of the regulation of classical VEGF and VEGF receptors. I propose that by extending such studies we will gain deeper insights into how we might combat the progression of breast cancer by controlling hormone-dependent angiogenesis within tumor tissue. I believe that information gained from such studies will permit us to target angiogenic growth factors and their initiated signal transduction pathways in a more precise and selective manner, and thereby to control the formation of new blood vessels that fuel the rapid growth of breast tumors. Finally, it is my hope that the concepts discussed here will help elucidate molecular targets in the hormone-dependent angiogenesis pathway that will ultimately allow us to overcome anti-hormone resistance and to provide insights into how we might pursue the concept of chemoprevention by considering \u2018angioprevention\u2019 as the end point.<\/jats:p>","DOI":"10.1677\/erc.1.00931","type":"journal-article","created":{"date-parts":[[2006,9,5]],"date-time":"2006-09-05T15:13:24Z","timestamp":1157469204000},"page":"667-687","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":47,"title":["Sex-steroid regulation of vascular endothelial growth factor in breast cancer"],"prefix":"10.1530","volume":"13","author":[{"given":"S M","family":"Hyder","sequence":"first","affiliation":[{"name":"Dalton Cardiovascular Research Center, Department of Biomedical Sciences, University of Missouri, 134 Research Park Drive, Columbia, Missouri 65211, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"2026070905570035900_ADER-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Ader\n            DN\n          , South-Paul J, Adera T & Deutser PA 2001 Cyclical mastalgia: prevalence and associated health and behavioral factors. Journal of Psychosomatic Obstetrics and Gynaecology2271\u201376.","DOI":"10.3109\/01674820109049956"},{"key":"2026070905570035900_AKIRI-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Akiri\n            G\n          , Nahari D, Finkelstein Y, Le SY, Elroy-Stein O & Levi BZ 1998 Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription. Oncogene17227\u2013236.","DOI":"10.1038\/sj.onc.1202019"},{"key":"2026070905570035900_ANAN-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Anan\n            K\n          , Morisaki T, Katano M, Ibuko A, Kitsuki H, Uchiyama A, Kuroki S, Tanaka M & Torisu M 1996 Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer. Surgery119333\u2013339.","DOI":"10.1016\/S0039-6060(96)80120-6"},{"key":"2026070905570035900_ANDERSON-ETAL-1982","doi-asserted-by":"crossref","unstructured":"Anderson\n            TJ\n          , Ferguson DJ & Raab GM 1982 Cell turnover in the \u2018resting\u2019 human breast: influence of parity, contraceptive pill, age and laterality. British Journal of Cancer46376\u2013382.","DOI":"10.1038\/bjc.1982.213"},{"key":"2026070905570035900_ANGIOLILLO-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Angiolillo\n            AL\n          , Sgadari C, Taub DD, Liao F, Farber JM, Maheshwari S, Kleinman HK, Reaman GH & Tosato G 1995 Human interferon inducible protein 10 is a potent inhibitor of angiogenesis in vivo. Journal of Experimental Medicine182155\u2013162.","DOI":"10.1084\/jem.182.1.155"},{"key":"2026070905570035900_ARMSTRONG-AND-BORNSTEIN-2003","doi-asserted-by":"crossref","unstructured":"Armstrong\n            LC\n           & Bornstein P 2003 Thrombospondins 1 and 2 function as inhibitors of angiogenesis. Matrix Biology2263\u201371.","DOI":"10.1016\/S0945-053X(03)00005-2"},{"key":"2026070905570035900_ARONICA-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Aronica\n            SM\n          , Fanti P, Kaminskaya K, Gibbs K, Raiber L, Nazareth M, Bucelli R, Mineo M, Grzybek K, Kumin M et al.2004 Estrogen disrupts chemokine-mediated chemokine release from mammary cells: implications for the interplay between estrogen and IP-10 in the regulation of mammary tumor formation. Breast Cancer Research and Treatment84235\u2013245.","DOI":"10.1023\/B:BREA.0000019961.59306.f6"},{"key":"2026070905570035900_ASAHARA-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Asahara\n            T\n          , Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbicher N, Schnatteman G & Isner JM 1997 Isolation of putative progenitor endothelial cells for angiogenesis. Science275964\u2013967.","DOI":"10.1126\/science.275.5302.964"},{"key":"2026070905570035900_ASAHARA-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Asahara\n            T\n          , Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M & Isner JM 1999 VEGF contributes to post natal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO Journal183964\u20133972.","DOI":"10.1093\/emboj\/18.14.3964"},{"key":"2026070905570035900_ATQUR-REHMAN-AND-TOI-2003","unstructured":"Atqur-Rehman\n            MA\n           & Toi M 2003 Anti-angiogenic therapy in breast cancer. Biomedicine and Pharmacotherapy57463\u2013470."},{"key":"2026070905570035900_AUGUSTIN-2005","doi-asserted-by":"crossref","unstructured":"Augustin\n            HG\n          \n          2005 Angiogenesis in the female reproductive system. EXS9435\u201352.","DOI":"10.1007\/3-7643-7311-3_3"},{"key":"2026070905570035900_BALLARE-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Ballare\n            C\n          , Uhrig M, Bechtold T, Sancho E, Domenico MD, Migliaccio A, Auricchio F & Beaot M 2003 Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-src\/Erk pathway in mammalian cells. Molecular and Cellular Biology231994\u20132008.","DOI":"10.1128\/MCB.23.6.1994-2008.2003"},{"key":"2026070905570035900_BARLEON-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Barleon\n            B\n          , Sozzani S, Zhou D, Weich HA, Mantovani A & Marme D 1996 Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGT receptor flt-1. Blood873336\u20133343.","DOI":"10.1182\/blood.V87.8.3336.bloodjournal8783336"},{"key":"2026070905570035900_BENAKANAKERE-ETAL-2005","unstructured":"Benakanakere\n            I\n          , Besch-Williford C, Schnell JD & Hyder SM 2005 Natural and synthetic progestins accelerate tumor development and increase VEGF production in a chemically induced mammary tumor model: a potentially novel target for anti-angiogenic therapeutics. AACR Special Conference in Advances in Breast Cancer, San Diego, CA. Abstract A15."},{"key":"2026070905570035900_BERGERS-AND-BENJAMIN-2003","doi-asserted-by":"crossref","unstructured":"Bergers\n            G\n           & Benjamin LE 2003 Tumorigenesis and the angiogenic switch. Nature Reviews Cancer3401\u2013410.","DOI":"10.1038\/nrc1093"},{"key":"2026070905570035900_BERMONT-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Bermont\n            L\n          , Lamielle-Musard F, Chezy E, Weisz A & Adessi GL 2001 17\u03b2-estradiol inhibits forskolin-induced vascular endothelial growth factor promoter in MCF-7 breast adenocarcinoma cells. Journal of Steroid Biochemistry and Molecular Biology78343\u2013349.","DOI":"10.1016\/S0960-0760(01)00111-X"},{"key":"2026070905570035900_BLAGOSKLONNY-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Blagosklonny\n            MV\n          , An WG, Romanova LY, Trepel J, Fojo T & Neckers L 1998 p53 inhibits hypoxia-inducible factor-stimulated transcription. Journal of Biological Chemistry27311995\u201311998.","DOI":"10.1074\/jbc.273.20.11995"},{"key":"2026070905570035900_BOGIN-AND-DEGANI-2002","unstructured":"Bogin\n            L\n           & Degani H 2002 Hormonal regulation of VEGF in orthotopic MCF7 human breast cancer. Cancer Research621948\u20131951."},{"key":"2026070905570035900_BORGSTROM-ETAL-1999","unstructured":"Borgstrom\n            P\n          , Gold DP, Hillan KJ & Ferrara N 1999 Importance of VEGF for breast cancer angiogenesis in vivo: implications from intravital microscopy of combination treatments with an anti-VEGF neutralizing monoclonal antibody and doxorubicin. Anticancer Research194203\u20134214."},{"key":"2026070905570035900_BOS-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Bos\n            R\n          , Zhong H, Hanrahan CF, Mommers EC, Semenza GL, Pinedo HM, Abeloff MD, Simons JW, van Diest PJ & van der Wall E 2001 Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. Journal of the National Cancer Institute93309\u2013314.","DOI":"10.1093\/jnci\/93.4.309"},{"key":"2026070905570035900_BOS-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Bos\n            R\n          , van Diest PJ, de Jong JS, van der Groep P, van der Valk P & van der Wall E 2005 Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. Histopathology4631\u201336.","DOI":"10.1111\/j.1365-2559.2005.02045.x"},{"key":"2026070905570035900_BREM-ETAL-1977","doi-asserted-by":"crossref","unstructured":"Brem\n            SS\n          , Gullino PM & Medina D 1977 Angiogenesis: a marker for neoplastic transformation of mammary papillary hyperplasia. Science195880\u2013882.","DOI":"10.1126\/science.402692"},{"key":"2026070905570035900_BRENNER-AND-SLAYDEN-1994","unstructured":"Brenner\n            RM\n           & Slayden OD 1994 Cyclic changes in the primate oviduct and endometrium. In The Physiology of Reproduction, vol 1, pp 541\u2013569. Eds E Knobil & JD Neill. New York: Raven Press."},{"key":"2026070905570035900_BROWN-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Brown\n            LF\n          , Berse B, Jackman RW, Toguazzi K, Guidi AJ, Dvorak HF, Senger DR, Connolly JL & Schnitt SJ 1995 Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Human Pathology2686\u201391.","DOI":"10.1016\/0046-8177(95)90119-1"},{"key":"2026070905570035900_BUTEAU-LOZANO-ETAL-2002","unstructured":"Buteau-Lozano\n            H\n          , Ancelin M, Lardeux B, Milanini J & Perrot-Applanat M 2002 Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Cancer Research624977\u20134984."},{"key":"2026070905570035900_CAPILLO-ETAL-2003","unstructured":"Capillo\n            M\n          , Mancuso P, Gobbi A, Monestirolo G, Pruneri G, Del\u2019Agnola C, Martinelli G, Shultz L & Bertolini F 2003 Continuous infusion of endostatin inhibits differentiation, mobilization, and clonogenic potential of endothelial cell progenitors. Clinical Cancer Research9377\u2013382."},{"key":"2026070905570035900_CARMELIET-2005","unstructured":"Carmeliet\n            P\n          \n          2005 Angiogenesis in life, disease, and medicine. Nature438932\u2013936."},{"key":"2026070905570035900_CHEN-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Chen\n            WY\n          , Hankinson SE, Schnitt SJ, Rosner BA, Holmes MD & Colditz GA 2004 Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma. Cancer1011490\u20131500.","DOI":"10.1002\/cncr.20499"},{"key":"2026070905570035900_CHLEBOWSKI-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Chlebowski\n            RT\n          , Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr MG, Thomson CA et al.2003 Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women\u2019s Health Initiative Randomized Trial. Journal of the American Medical Association2893243\u20133253.","DOI":"10.1001\/jama.289.24.3243"},{"key":"2026070905570035900_CLARKE-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Clarke\n            R\n          , Leonessa F, Welch JN & Skaar TC 2001 Cellular and molecular pharmacology of antiestrogen action and resistance. Pharmacological Reviews5325\u201371.","DOI":"10.1016\/S0031-6997(24)01479-0"},{"key":"2026070905570035900_COLACURCI-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Colacurci\n            N\n          , Foraro F, DeFranciscis P, Palermo M & del Vecchio W 2001 Effects of different types of hormone replacement therapy on mammographic density. Maturitas40159\u2013164.","DOI":"10.1016\/S0378-5122(01)00232-8"},{"key":"2026070905570035900_CONNELLY-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Connelly\n            OM\n          , Jericevic BM & Lydon JP 2003 Progesterone receptors in mammary gland development and tumorigenesis. Journal of Mammary Gland Biology and Neoplasia8205\u2013214.","DOI":"10.1023\/A:1025952924864"},{"key":"2026070905570035900_CORADINI-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Coradini\n            D\n          , Pellizzaro C, Speranza A & Daidone MG 2004 Hypoxia and estrogen receptor profile influence the responsiveness of human breast cancer cells to estradiol and antiestrogens. Cellular and Molecular Life Sciences6176\u201382.","DOI":"10.1007\/s00018-003-3324-0"},{"key":"2026070905570035900_CRONAUER-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Cronauer\n            MV\n          , Hittmair A, Eder IE, Hobisch A, Culig Z, Ramoner R, Zhang J, Bartsch G, Reissigl A, Radmayr C et al.1997 Basic fibroblast growth factor levels in cancer cells and in sera of patients suffering from proliferative disorders of the prostate. Prostate31223\u2013233.","DOI":"10.1002\/(SICI)1097-0045(19970601)31:4<223::AID-PROS3>3.0.CO;2-L"},{"key":"2026070905570035900_CULLINAN-BOVE-AND-KOOS-1993","doi-asserted-by":"crossref","unstructured":"Cullinan-Bove\n            K\n           & Koos RD 1993 Vascular endothelial growth factor\/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology133829\u2013837.","DOI":"10.1210\/endo.133.2.8344219"},{"key":"2026070905570035900_DABROSIN-2003","doi-asserted-by":"crossref","unstructured":"Dabrosin\n            C\n          \n          2003 Variability of vascular endothelial normal human breast tissue in vivo during the menstrual cycle. Journal of Clinical Endocrinology and Metabolism882695\u20132698.","DOI":"10.1210\/jc.2002-021584"},{"key":"2026070905570035900_DABROSIN-2005A","doi-asserted-by":"crossref","unstructured":"Dabrosin\n            C\n          \n          2005a Sex steroid regulation of angiogenesis in breast tissue. Angiogenesis8127\u2013136.","DOI":"10.1007\/s10456-005-9002-0"},{"key":"2026070905570035900_DABROSIN-2005B","doi-asserted-by":"crossref","unstructured":"Dabrosin\n            C\n          \n          2005b Positive correlation between estradiol and vascular endothelial growth factor but not fibroblast growth factor-2 in normal human breast tissue in vivo. Clinical Cancer Research118036\u20138041.","DOI":"10.1158\/1078-0432.CCR-05-0977"},{"key":"2026070905570035900_DABROSIN-ETAL-2003A","doi-asserted-by":"crossref","unstructured":"Dabrosin\n            C\n          , Margetts PJ & Gauldie J 2003a Estradiol increases extracellular levels of vascular endothelial growth factor in vivo in murine mammary cancer. International Journal of Cancer107535\u2013540.","DOI":"10.1002\/ijc.11398"},{"key":"2026070905570035900_DABROSIN-ETAL-2003B","doi-asserted-by":"crossref","unstructured":"Dabrosin\n            C\n          , Palmer K, Muller WJ & Gauldie J 2003b Estradiol promotes growth and an giogenesis in polyoma middle T transgenic mouse mammary tumor explants. Breast Cancer Research and Treatment781\u20136.","DOI":"10.1023\/A:1022133219353"},{"key":"2026070905570035900_DE-FATTA-ETAL-1999","doi-asserted-by":"crossref","unstructured":"De Fatta\n            RJ\n          , Turbat-Herrera EA, Li BD, Anderson W & De Benedetti A 1999 Elevated expression of eIF4E in confined early breast cancer lesions: possible role of hypoxia. International Journal of Cancer80516\u2013522.","DOI":"10.1002\/(SICI)1097-0215(19990209)80:4<516::AID-IJC6>3.3.CO;2-Z"},{"key":"2026070905570035900_DE-LARCO-ETAL-2001","doi-asserted-by":"crossref","unstructured":"De Larco\n            JE\n          , Wuertz BR, Rosner KA, Erickson SA, Gamache DE, Manivel JC & Furcht LT 2001 A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells. American Journal of Pathology158639\u2013646.","DOI":"10.1016\/S0002-9440(10)64005-9"},{"key":"2026070905570035900_DIAS-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Dias\n            S\n          , Thomas H & Balkwill F 1998 Multiple molecular and cellular changes associated with tumour stasis and regression during IL-12 therapy of a murine breast cancer model. International Journal of Cancer75151\u2013157.","DOI":"10.1002\/(SICI)1097-0215(19980105)75:1<151::AID-IJC23>3.0.CO;2-I"},{"key":"2026070905570035900_DVORAK-ETAL-1995","unstructured":"Dvorak\n            HF\n          , Brown LF, Detmar M & Dvorak AM 1995 Vascular permeability factor\/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. American Journal of Pathology1461029\u20131039."},{"key":"2026070905570035900_ELKIN-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Elkin\n            M\n          , Orgel A & Kleinman HK 2004 An angiogenic switch in breast cancer involves estrogen and soluble vascular endothelial growth factor receptor 1. Journal of the National Cancer Institute96875\u2013878.","DOI":"10.1093\/jnci\/djh140"},{"key":"2026070905570035900_ENGELS-ETAL-1997A","doi-asserted-by":"crossref","unstructured":"Engels\n            K\n          , Fox SB, Whitehouse RM, Gatter KC & Harris AL 1997a Distinct angiogenic patterns are associated with high-grade in situ ductal carcinomas of the breast. Journal of Pathology181207\u2013212.","DOI":"10.1002\/(SICI)1096-9896(199702)181:2<207::AID-PATH758>3.3.CO;2-W"},{"key":"2026070905570035900_ENGELS-ETAL-1997B","doi-asserted-by":"crossref","unstructured":"Engels\n            K\n          , Fox SB, Whitehouse RM, Gatter KC & Harris AL 1997b Up-regulation of thymidine phophorylase expression is associated with a discrete pattern of angiogenesis in ductal carcinomas in situ of the breast. Journal of Pathology182414\u2013420.","DOI":"10.1002\/(SICI)1096-9896(199708)182:4<414::AID-PATH897>3.0.CO;2-Q"},{"key":"2026070905570035900_EREL-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Erel\n            CT\n          , Esen G, Seyisoglu H, Elter K, Uras C, Ertungealp E & Aksu MF 2001 Mammographic density increase in women receiving different hormone replacement regimens. Maturitas40151\u2013157.","DOI":"10.1016\/S0378-5122(01)00236-5"},{"key":"2026070905570035900_ERIKSSON-AND-ALITALO-1999","doi-asserted-by":"crossref","unstructured":"Eriksson\n            U\n           & Alitalo K 1999 Structure, expression, and receptor-binding properties of novel vascular endothelial growth factors. Current Topics in Microbiology and Immunology23741\u201357.","DOI":"10.1007\/978-3-642-59953-8_3"},{"key":"2026070905570035900_ESKENS-2004","doi-asserted-by":"crossref","unstructured":"Eskens\n            FALM\n          \n          2004 Angiogenesis inhibitors in clinical development; where are we now and where are we going? British Journal of Cancer901\u20137.","DOI":"10.1038\/sj.bjc.6601401"},{"key":"2026070905570035900_FERRARA-1999","doi-asserted-by":"crossref","unstructured":"Ferrara\n            N\n          \n          1999 Vascular endothelial growth factor: molecular and biological aspects. Current Topics in Microbiology and Immunology2371\u201330.","DOI":"10.1007\/978-3-642-59953-8_1"},{"key":"2026070905570035900_FERRARA-2004A","doi-asserted-by":"crossref","unstructured":"Ferrara\n            N\n          \n          2004a Vascular endothelial growth factor as a target for anticancer therapy. Oncologist92\u201310.","DOI":"10.1634\/theoncologist.9-suppl_1-2"},{"key":"2026070905570035900_FERRARA-2004B","unstructured":"Ferrara\n            N\n          \n          2004b Vascular endothelial growth factor: basic science and clinical progress. Endocrine Reviews25581\u2013611."},{"key":"2026070905570035900_FERRARA-2005","doi-asserted-by":"crossref","unstructured":"Ferrara\n            N\n          \n          2005 The role of VEGF in the regulation of physiological and pathological angiogenesis. EXS94209\u2013231.","DOI":"10.1007\/3-7643-7311-3_15"},{"key":"2026070905570035900_FERRARA-AND-DAVIS-SMYTH-1997","doi-asserted-by":"crossref","unstructured":"Ferrara\n            N\n           & Davis-Smyth T 1997 The biology of vascular endothelial growth factor. Endocrinology Reviews184\u201325.","DOI":"10.1210\/edrv.18.1.0287"},{"key":"2026070905570035900_FERRARA-AND-KERBEL-2005","unstructured":"Ferrara\n            N\n           & Kerbel RS 2005 Angiogenesis as a therapeutic target. Nature438967\u2013974."},{"key":"2026070905570035900_FERRARA-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Ferrara\n            N\n          , Gerber HP & LeCouter J 2003 The biology of VEGF and its receptors. Nature Medicine9669\u2013676.","DOI":"10.1038\/nm0603-669"},{"key":"2026070905570035900_FERRARA-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Ferrara\n            N\n          , Hillan KJ & Novotny W 2005 Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy. Biochemical and Biophysical Research Communications333289\u2013291.","DOI":"10.1016\/j.bbrc.2005.05.132"},{"key":"2026070905570035900_FINDLAY-1986","unstructured":"Findlay\n            JK\n          \n          1986 Angiogenesis in reproductive tissues. Journal of Endocrinology111357\u2013366."},{"key":"2026070905570035900_FOEKENS-ETAL-2001","unstructured":"Foekens\n            JA\n          , Peters HA, Grebenchtchikov N, Look MP, Meijer-van Gelder ME, Geurts-Moespot A, van der Kwast TH, Sweep CG & Klijn JG 2001 High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer. Cancer Research615407\u20135414."},{"key":"2026070905570035900_FOLKMAN-1995","unstructured":"Folkman\n            J\n          \n          1995 Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine127\u201331."},{"key":"2026070905570035900_FOLKMAN-1998","doi-asserted-by":"crossref","unstructured":"Folkman\n            J\n          \n          1998 Is tissue mass regulated by vascular endothelial cells? Prostate as the first evidence. Endocrinology139441\u2013442.","DOI":"10.1210\/endo.139.2.5858"},{"key":"2026070905570035900_FOLKMAN-2003","doi-asserted-by":"crossref","unstructured":"Folkman\n            J\n          \n          2003 Fundamental concepts of the angiogenic process. Current Molecular Medicine3643\u2013651.","DOI":"10.2174\/1566524033479465"},{"key":"2026070905570035900_FOLKMAN-AND-HANAHAN-1991","unstructured":"Folkman\n            J\n           & Hanahan D 1991 Switch to the angiogenic phenotype during tumorigenesis. Princess Takamatsu Symposium22339\u2013347."},{"key":"2026070905570035900_FOX-ETAL-1991","doi-asserted-by":"crossref","unstructured":"Fox\n            HS\n          , Bond BL & Parslow TG 1991 Estrogen regulates the IFN gamma promoter. Journal of Immunology1464362\u20134367.","DOI":"10.4049\/jimmunol.146.12.4362"},{"key":"2026070905570035900_GARVIN-AND-DABROSIN-2003","unstructured":"Garvin\n            S\n           & Dabrosin C 2003 Tamoxifen inhibits secretion of vascular endothelial growth factor in breast cancer in vivo. Cancer Research638742\u20138748."},{"key":"2026070905570035900_GARVIN-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Garvin\n            S\n          , Nilsson UW & Dabrosin C 2005 Effects of oestradiol and tamoxifen on VEGF, soluble VEGFR-1, and VEGFR-2 in breast cancer and endothelial cells. British Journal of Cancer931005\u20131010.","DOI":"10.1038\/sj.bjc.6602824"},{"key":"2026070905570035900_GASPARINI-1997","doi-asserted-by":"crossref","unstructured":"Gasparini\n            G\n          \n          1997 Angiogenesis in endocrine-related cancer. Endocrine-Related Cancer4423\u2013445.","DOI":"10.1677\/erc.0.0040423"},{"key":"2026070905570035900_GASPARINI-2000","doi-asserted-by":"crossref","unstructured":"Gasparini\n            G\n          \n          2000 Prognostic value of vascular endothelial growth factor in breast cancer. Oncologist5S37\u2013S44.","DOI":"10.1634\/theoncologist.5-suppl_1-37"},{"key":"2026070905570035900_GASPARINI-ETAL-1999","unstructured":"Gasparini\n            G\n          , Toi M, Miceli R, Vermuelen PB, Dittadi R, Biganzoli E, Morabito A, Fanell M, Gatti C, Suzuki H et al.1999 Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy. Cancer Journal from Scientific American5101\u2013111."},{"key":"2026070905570035900_GASPARINI-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Gasparini\n            G\n          , Longo R, Torino F & Morabito A 2005 Therapy of breast cancer with molecular targeting agents. Annals of Oncology16 (Suppl 4) iv28\u2013iv36.","DOI":"10.1093\/annonc\/mdi905"},{"key":"2026070905570035900_GIMBRONE-JR-AND-GULLION-1976","unstructured":"Gimbrone\n            MA\n           Jr & Gullion PM 1976 Angiogenic capacity of preneoplastic lesions of the murine mammary gland as a marker of neoplastic transformation. Cancer Research362611\u20132620."},{"key":"2026070905570035900_GOLDBERG-AND-ROSEN-1997","doi-asserted-by":"crossref","unstructured":"Goldberg\n            ID\n           & Rosen EM 1997 Regulation of angiogenesis. EXS79.","DOI":"10.1007\/978-3-0348-9006-9"},{"key":"2026070905570035900_GREB-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Greb\n            RR\n          , Heikinheimo O, Williams RF, Hodgen GD & Goodman AL 1997 Vascular endothelial growth factor in primate endometrium is regulated by oestrogen-receptor and progesterone-receptor ligands in vivo. Human Reproduction121280\u20131292.","DOI":"10.1093\/humrep\/12.6.1280"},{"key":"2026070905570035900_GUIDI-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Guidi\n            AJ\n          , Fischer L, Harris JR & Schnitt SJ 1994 Microvessel density and distribution in ductal carcinoma in situ of the breast. Journal of the National Cancer Institute86614\u2013619.","DOI":"10.1093\/jnci\/86.8.614"},{"key":"2026070905570035900_GUIDI-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Guidi\n            AJ\n          , Schnitt SJ, Fischer L, Tognazzi K, Harris JR, Dvorak HF & Brown LF 1997 Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast. Cancer151945\u20131953.","DOI":"10.1002\/(SICI)1097-0142(19971115)80:10<1945::AID-CNCR11>3.0.CO;2-Y"},{"key":"2026070905570035900_GUINEBRETIERE-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Guinebretiere\n            JM\n          , LeMonique G, Gavoille A, Bahi J & Contesso G 1994 Angiogenesis and risk of breast cancer in women with fibrocystic disease. Journal of the National Cancer Institute86635\u2013636.","DOI":"10.1093\/jnci\/86.8.635"},{"key":"2026070905570035900_GUTIERREZ-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Gutierrez\n            MC\n          , Detre S, Johnston S, Mohsin SK, Shou J, Allred DC, Schiff R, Osborne CK & Dowsett M 2005 Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase. Journal of Clinical Oncology232469\u20132476.","DOI":"10.1200\/JCO.2005.01.172"},{"key":"2026070905570035900_HICKLIN-AND-ELLIS-2005","doi-asserted-by":"crossref","unstructured":"Hicklin\n            DJ\n           & Ellis LM 2005 Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. Journal of Clinical Oncology231011\u20131027.","DOI":"10.1200\/JCO.2005.06.081"},{"key":"2026070905570035900_HOEBEN-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Hoeben\n            A\n          , Landuyt B, Highley MS, Wildiers H, Van Oosterom AT & De Bruijn EA 2004 Vascular endothelial growth factor and angiogenesis. Pharmacological Review56549\u2013580.","DOI":"10.1124\/pr.56.4.3"},{"key":"2026070905570035900_HUH-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Huh\n            JI\n          , Calvo A, Stafford J, Cheung M, Kumar R, Philp D, Kleinman HK & Green JE 2004 Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)\/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms. Oncogene24790\u2013800.","DOI":"10.1038\/sj.onc.1208221"},{"key":"2026070905570035900_HYDER-2002","unstructured":"Hyder\n            SM\n          \n          2002 The role of steroid hormones on the regulation of vascular endothelial growth factor. American Journal Pathology161345\u2013346."},{"key":"2026070905570035900_HYDER-AND-STANCEL-1999","doi-asserted-by":"crossref","unstructured":"Hyder\n            SM\n           & Stancel GM 1999 Regulation of angiogenic growth factors in the female reproductive tract by estrogens and progestins. Molecular Endocrinology13806\u2013811.","DOI":"10.1210\/mend.13.6.0308"},{"key":"2026070905570035900_HYDER-AND-STANCEL-2000","unstructured":"Hyder\n            SM\n           & Stancel GM 2000 Regulation of VEGF in the reproductive tract by sex-steroid hormones. Histology and Histopathology15325\u2013334."},{"key":"2026070905570035900_HYDER-AND-STANCEL-2002","doi-asserted-by":"crossref","unstructured":"Hyder\n            SM\n           & Stancel GM 2002 Inhibition of progesterone-induced VEGF production in human breast cancer cells by the pure antiestrogen ICI 182,780. Cancer Letters18147\u201353.","DOI":"10.1016\/S0304-3835(02)00048-4"},{"key":"2026070905570035900_HYDER-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Hyder\n            SM\n          , Nawaz Z, Chiappetta C, Yokoyama K & Stancel GM 1995 The protooncogene c-jun contains an unusual estrogen-inducible enhancer within the coding sequence. Journal of Biological Chemistry2708506\u20138513.","DOI":"10.1074\/jbc.270.15.8506"},{"key":"2026070905570035900_HYDER-ETAL-1996","unstructured":"Hyder\n            SM\n          , Stancel GM, Chiappetta C, Murthy L, Boettger-Tong HL & Makela S 1996 Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen. Cancer Research563954\u20133960."},{"key":"2026070905570035900_HYDER-ETAL-1997","unstructured":"Hyder\n            SM\n          , Chiappetta C, Murthy L & Stancel GM 1997 Selective inhibition of estrogen-regulated gene expression in vivo by the pure antiestrogen ICI 182,780. Cancer Research572547\u20132549."},{"key":"2026070905570035900_HYDER-ETAL-1998","unstructured":"Hyder\n            SM\n          , Murthy L & Stancel GM 1998 Progestin regulation of vascular endothelial growth factor in human breast cancer cells. Cancer Research58392\u2013395."},{"key":"2026070905570035900_HYDER-ETAL-2000A","unstructured":"Hyder\n            SM\n          , Nawaz Z, Chiappetta C & Stancel GM 2000a Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. Cancer Research603183\u20133190."},{"key":"2026070905570035900_HYDER-ETAL-2000B","doi-asserted-by":"crossref","unstructured":"Hyder\n            SM\n          , Huang JC, Nawaz Z, Boettger-Tong H, Makela S, Chiappetta C & Stancel GM 2000b Regulation of vascular endothelial growth factor expressions by estrogens and progestins. Environmental Health Perspectives108785\u2013790.","DOI":"10.2307\/3454307"},{"key":"2026070905570035900_HYDER-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Hyder\n            SM\n          , Chiappetta C & Stancel GM 2001 Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells. International Journal of Cancer92469\u2013473.","DOI":"10.1002\/ijc.1236"},{"key":"2026070905570035900_JAIN-2005","unstructured":"Jain\n            R\n          \n          2005 Normalization of tumor vasculature: an emerging concept in anti-angiogenic therapy. Science30758\u201362."},{"key":"2026070905570035900_JAIN-ETAL-2006","doi-asserted-by":"crossref","unstructured":"Jain\n            RK\n          , Duda DG, Clark JW & Loeffler JS 2006 Lessons from phase III clinical trials on anti-VEGF therapy for cancer. Nature Clinical Practice & Oncology324\u201340.","DOI":"10.1038\/ncponc0403"},{"key":"2026070905570035900_JELTSCH-ETAL-1997","unstructured":"Jeltsch\n            M\n          , Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, Swartz M, Fukumura D, Jain RK, Alitalo K 1997. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science2761423\u20131425. Erratum in: Science277 463."},{"key":"2026070905570035900_JENSEN-ETAL-1982","doi-asserted-by":"crossref","unstructured":"Jensen\n            HM\n          , Chen I, DeVault MF & Lewis AE 1982 Angiogenesis induced by \u201cnormal\u201d human breast tissue: a probable marker for precancer. Science218293\u2013295.","DOI":"10.1126\/science.6181563"},{"key":"2026070905570035900_DE-JONG-ETAL-1998","doi-asserted-by":"crossref","unstructured":"de Jong\n            JS\n          , van Diest PJ, van der Valk P & Baak JP 1998 Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops. Journal of Pathology18444\u201352.","DOI":"10.1002\/(SICI)1096-9896(199801)184:1<44::AID-PATH984>3.0.CO;2-H"},{"key":"2026070905570035900_KAKLAMANI-AND-GRADISHAR-2005","doi-asserted-by":"crossref","unstructured":"Kaklamani\n            VG\n           & Gradishar WJ 2005 Adjuvant therapy of breast cancer. Cancer Investigation23548\u2013560.","DOI":"10.1001\/jama.293.9.1118"},{"key":"2026070905570035900_KAZI-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Kazi\n            AA\n          , Jones JM & Koos RD 2005 Chromatin immunoprecipitation analysis of gene expression in the rat uterus in vivo: estrogen-induced recruitment of both estrogen receptor alpha and hypoxia inducible factor 1 to the vascular endothelial growth factor promoter. Molecular Endocrinology192006\u20132019.","DOI":"10.1210\/me.2004-0388"},{"key":"2026070905570035900_KEVIL-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Kevil\n            CG\n          , De Benedetti A, Payne DK, Coe LL, Laroux FS & Alexander JS 1996 Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: implications for tumor angiogenesis. International Journal of Cancer65785\u2013790.","DOI":"10.1002\/(SICI)1097-0215(19960315)65:6<785::AID-IJC14>3.0.CO;2-3"},{"key":"2026070905570035900_KHALKHALI-ELLIS-ETAL-2004","unstructured":"Khalkhali-Ellis\n            Z\n          , Christian AL, Kirschmann DA, Edwards EM, Rezaie-Thompson M, Vasef MA, Gruman LM, Seftor RE, Norwood LE & Hendrix MJ 2004 Regulating the tumor suppressor gene maspin in breast cancer cells: a potential mechanism for the anticancer properties of tamoxifen. Clinical Cancer Research10449\u2013454."},{"key":"2026070905570035900_KOGA-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Koga\n            K\n          , Osuga Y, Yoshino O, Hirota Y, Fuimeng X, Hirata T, Takea S, Yano T, Tsutmi O & Taketami Y 2003 Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. Journal of Clinical Endocrinology and Metabolism882348\u20132351.","DOI":"10.1210\/jc.2002-021942"},{"key":"2026070905570035900_KRIPPL-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Krippl\n            P\n          , Langsenlehner U, Renner W, Yazdani-Biuki B, Wolf G, Wascer TG, Paulweber B, Haas J & Samonigg H 2003 A common 936 C\/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. International Journal of Cancer106468\u2013471.","DOI":"10.1002\/ijc.11238"},{"key":"2026070905570035900_KRIPPL-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Krippl\n            P\n          , Langsenlehner U, Samonigg H, Renner W & Koppel H 2004 Vascular endothelial growth factor in predicting outcome in breast cancer. Clinical Cancer Research108752\u20138753.","DOI":"10.1158\/1078-0432.CCR-04-1211"},{"key":"2026070905570035900_KUCAB-AND-DUNN-2003","doi-asserted-by":"crossref","unstructured":"Kucab\n            JE\n           & Dunn SE 2003 Role of IGF-1R in mediating breast cancer invasion and metastasis. Breast Disease1741\u201347.","DOI":"10.3233\/BD-2003-17105"},{"key":"2026070905570035900_KUREBAYASHI-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Kurebayashi\n            J\n          , Otsuki T, Moriya T & Sonoo H 2001 Hypoxia reduces hormone responsiveness of human breast cancer cells. Japanese Journal of Cancer Research921093\u20131101.","DOI":"10.1111\/j.1349-7006.2001.tb01064.x"},{"key":"2026070905570035900_LANARI-AND-MOLINOLO-2002","doi-asserted-by":"crossref","unstructured":"Lanari\n            C\n           & Molinolo A 2002 Progesterone receptors\u2013animal models and cell signaling in breast cancer, diverse activation pathways for the progesterone receptor: possible implications for breast biology and cancer. Breast Cancer Research4240\u2013243.","DOI":"10.1186\/bcr539"},{"key":"2026070905570035900_LEE-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Lee\n            AH\n          , Dublin EA, Bobrow LG & Poulsom R 1998 Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis. Journal of Pathology185394\u2013401.","DOI":"10.1002\/(SICI)1096-9896(199808)185:4<394::AID-PATH117>3.0.CO;2-S"},{"key":"2026070905570035900_LEE-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Lee\n            HJ\n          , Cho CH, Hwang SJ, Choi HH, Kim KT, Ahn Sy, On JL, Lee GM & Koh GY 2004 Biological characterization of angiopoietin-3 and angiopoietin-4. FASEB Journal181200\u20131208.","DOI":"10.1096\/fj.03-1466com"},{"key":"2026070905570035900_LIANG-AND-HYDER-2005","doi-asserted-by":"crossref","unstructured":"Liang\n            Y\n           & Hyder SM 2005 Proliferation of endothelial and tumor epithelial cells by progestin-induced vascular endothelial growth factor from human breast cancer cells: paracrine and autocrine effects. Endocrinology1463632\u20133641.","DOI":"10.1210\/en.2005-0103"},{"key":"2026070905570035900_LIANG-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Liang\n            Y\n          , Wu J & Hyder SM 2005 p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells. Journal of Steroid Biochemistry and Molecular Biology93173\u2013182.","DOI":"10.1016\/j.jsbmb.2004.12.011"},{"key":"2026070905570035900_LICHTENBELD-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Lichtenbeld\n            HC\n          , Barendsz-Janson AF, ven Essen H, Struijker Boudeier H, Griffioen AW & Hillen HF 1998 Angiogenic potential of malignant and non-malignant human breast tissues in an in vivo angiogenesis model. International Journal of Cancer77455\u2013459.","DOI":"10.1002\/(SICI)1097-0215(19980729)77:3<455::AID-IJC23>3.0.CO;2-5"},{"key":"2026070905570035900_LIN-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Lin\n            Y\n          , Huang R, Chen L, Li S, Shi Q, Jordan C & Huang RP 2004 Identification of interleukin-8 as estrogen receptor-regulated factor involved in breast cancer invasion and angiogenesis by protein arrays. International Journal of Cancer109507\u2013515.","DOI":"10.1002\/ijc.11724"},{"key":"2026070905570035900_LINDERHOLM-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Linderholm\n            B\n          , Travelin B, Grankvist K & Henriksson R 1998 Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma. Journal of Clinical Oncology163121\u20133128.","DOI":"10.1016\/S0959-8049(97)89252-0"},{"key":"2026070905570035900_LINDERHOLM-ETAL-2000A","doi-asserted-by":"crossref","unstructured":"Linderholm\n            B\n          , Lindh B, Tavelin B, Grankvist K & Henriksson R 2000a p53 and vascular-endothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma. International Journal of Cancer8951\u201362.","DOI":"10.1002\/(SICI)1097-0215(20000120)89:1<51::AID-IJC9>3.3.CO;2-#"},{"key":"2026070905570035900_LINDERHOLM-ETAL-2000B","doi-asserted-by":"crossref","unstructured":"Linderholm\n            B\n          , Grankvist K, Wilking N, Johansson M, Tavelin B & Henriksson R 2000b Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant therapy. Journal of Clinical Oncology181423\u20131431.","DOI":"10.1200\/JCO.2000.18.7.1423"},{"key":"2026070905570035900_LINDERHOLM-ETAL-2001","unstructured":"Linderholm\n            BK\n          , Lindhal T, Holmberg L, Klaar S, Lennerstrand J, Henriksson R & Bergh J 2001 The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer. Cancer Research612256\u20132260."},{"key":"2026070905570035900_LIU-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Liu\n            Z\n          , Shi HY, Nawaz Z & Zhang M 2004 Tamoxifen induces the expression of maspin through estrogen receptor-alpha. Cancer Letters20955\u201365.","DOI":"10.1016\/j.canlet.2003.11.018"},{"key":"2026070905570035900_LONGO-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Longo\n            R\n          , Sarmiento R, Fanelli M, Capaccetti B, Gattuso D & Gasparini G 2002 Anti-angiogenic therapy: rationale, challenges and clinical studies. Angiogenesis5237\u2013256.","DOI":"10.1023\/A:1024532022166"},{"key":"2026070905570035900_LOSORDO-AND-ISNER-2001","doi-asserted-by":"crossref","unstructured":"Losordo\n            DW\n           & Isner JM 2001 Estrogen and angiogenesis: a review. Arteriosclerosis Thrombosis and Vascular Biology216\u201312.","DOI":"10.1161\/01.ATV.21.1.6"},{"key":"2026070905570035900_LYDEN-ETAL-2001","unstructured":"Lyden\n            D\n          , Hattori K & Dias S 2001 Impaired recruitment of bone marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nature Medicine71194\u20131201."},{"key":"2026070905570035900_MCLESKEY-ETAL-1998","doi-asserted-by":"crossref","unstructured":"McLeskey\n            SW\n          , Tobias CA, Vezza PR, Filie AC, Kern FG & Hanfelt J 1998 Tumor growth of FGF or VEGF transfected MCF-7 breast carcinoma cells correlates with density of specific microvessels independent of the transfected angiogenic factor. American Journal of Pathology1531993\u20132006.","DOI":"10.1016\/S0002-9440(10)65713-6"},{"key":"2026070905570035900_MAIORANA-AND-GULLINO-1978","unstructured":"Maiorana\n            A\n           & Gullino PM 1978 Acquisition of angiogenic capacity and neoplastic transformation in the rat mammary gland. Cancer Research384409\u20134414."},{"key":"2026070905570035900_MAMANE-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Mamane\n            Y\n          , Petroulakis E, Rong L, Yoshida K, Ler LW & Sonenberg N 2004 eIF4E\u2013from translation to transformation. Oncogene233172\u20133179.","DOI":"10.1038\/sj.onc.1207549"},{"key":"2026070905570035900_MANDERS-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Manders\n            P\n          , Beex LV, Tjan-Heijnen VC, Span PN & Sweep CG 2003 Vascular endothelial growth factor is associated with the efficacy of endocrine therapy in patients with advanced breast carcinoma. Cancer982125\u20132132.","DOI":"10.1002\/cncr.11764"},{"key":"2026070905570035900_MARTIN-ETAL-1973","doi-asserted-by":"crossref","unstructured":"Martin\n            L\n          , Finn CA & Trinder G 1973 Hypertrophy and hyperplasia in the mouse uterus after oestrogen treatment: an autoradiographic study. Journal of Endocrinology56133\u2013144.","DOI":"10.1677\/joe.0.0560133"},{"key":"2026070905570035900_MEDINA-ETAL-2003","unstructured":"Medina\n            D\n          , Kittrell FS, Shepard A, Contreras A, Rosen JM & Lydon J 2003 Hormone dependence in premalignant mammary progression. Cancer Research631067\u20131072."},{"key":"2026070905570035900_METHENY-BARLOW-AND-LI-2003","doi-asserted-by":"crossref","unstructured":"Metheny-Barlow\n            LJ\n           & Li LY 2003 The enigmatic role of angiopoietin-1 in tumor angiogenesis. Cell Research13309\u2013317.","DOI":"10.1038\/sj.cr.7290176"},{"key":"2026070905570035900_MEUNIER-CARPENTIER-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Meunier-Carpentier\n            S\n          , Dales JP, Djemli A, Garcia S, Bonnier P, Andrac-Meyer L, Lavaut MN, Allasia C & Charpin C 2005 Comparison of the prognosis indication of VEGFR-1 and VEGFR-2 and Tie2 receptor expression in breast carcinoma. International Journal of Oncology26977\u2013984.","DOI":"10.3892\/ijo.26.4.977"},{"key":"2026070905570035900_MEYER-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Meyer\n            M\n          , Clauss M, Lepple-Wienhues A, Waltenberger J, Augustin HG, Ziche M, Lanz C, Bitner M, Rziha HJ, Dehio C 1999 A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signaling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. EMBO Journal18363\u2013374.","DOI":"10.1093\/emboj\/18.2.363"},{"key":"2026070905570035900_MILANINI-MONGIAT-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Milanini-Mongiat\n            J\n          , Pouyssegur J & Pages G 2002 Identification of two Sp1 phosphorylation sites for p42\/p44 mitogen-activated protein kinases: their implication in vascular endothelial growth factor gene transcription. Journal of Biological Chemistry27720631\u201320639.","DOI":"10.1074\/jbc.M201753200"},{"key":"2026070905570035900_MIRKIN-AND-ARCHER-2004","doi-asserted-by":"crossref","unstructured":"Mirkin\n            S\n           & Archer DF 2004 Effects of mifepristone on vascular endothelial growth factor and thrombospondi-1 mRNA in Ishikawa cells: implications for endometrial effects of mifepristone. Contraception70327\u2013333.","DOI":"10.1016\/j.contraception.2004.05.001"},{"key":"2026070905570035900_MIRKIN-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Mirkin\n            S\n          , Wong BC & Archer DF 2005 Effect of 17\u03b2-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells. Fertility and Sterility84485\u2013491.","DOI":"10.1016\/j.fertnstert.2005.01.129"},{"key":"2026070905570035900_MOHSIN-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Mohsin\n            SK\n          , Zhang M, Clark GM & Craig Allred D 2003 Maspin expression in invasive breast cancer: association with other prognostic factors. Journal of Pathology199432\u2013435.","DOI":"10.1002\/path.1319"},{"key":"2026070905570035900_MOORE-2004","doi-asserted-by":"crossref","unstructured":"Moore\n            MR\n          \n          2004 A rationale for inhibiting progesterone-related pathways to combat breast cancer. Current Cancer Drug Targets4183\u2013189.","DOI":"10.2174\/1568009043481515"},{"key":"2026070905570035900_MORABITO-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Morabito\n            A\n          , Sarmiento R, Bonginelli P & Gasparini G 2004 Antiangiogenic strategies, compounds and early clinical results in breast cancer. Critical Reviews in Oncology\/Hematology4991\u2013107.","DOI":"10.1016\/S1040-8428(03)00168-9"},{"key":"2026070905570035900_MOSES-ETAL-2004","unstructured":"Moses\n            MA\n          , Harper J & Fernandez CA 2004 A role for antiangiogenic therapy in breast cancer. Current Oncology Report642\u201348."},{"key":"2026070905570035900_MUELLER-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Mueller\n            MD\n          , Vigne JL, Minchenko A, Lebovie Di, Leitman DC & Taylor RN 2000 Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta. PNAS9710972\u201310977.","DOI":"10.1073\/pnas.200377097"},{"key":"2026070905570035900_MUELLER-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Mueller\n            MD\n          , Vigne JL, Pritts EA, Chao V, Dreher E & Taylor RN 2003 Progestins activate vascular endothelial growth factor gene transcription in endometrial adenocarcinoma cells. Fertility and Sterility79386\u2013392.","DOI":"10.1016\/S0015-0282(02)04577-6"},{"key":"2026070905570035900_NAKAMURA-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Nakamura\n            J\n          , Savinvov A, Lu Q & Brodie A 1996 Estrogen regulates vascular endothelial growth\/permeability factor expression in 7,12-dimethylbenz(a) anthracene-induced rat mammary tumors. Endocrinology1375589\u20135596.","DOI":"10.1210\/endo.137.12.8940388"},{"key":"2026070905570035900_NAKAMURA-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Nakamura\n            J\n          , Lu Q, Aberdeen G, Albrecht E & Brodie A 1999 The effect of estrogen on aromatase and vascular endothelial growth factor messenger ribonucleic acid in the normal nonhuman primate mammary gland. Journal of Clinical Endocrinology and Metabolism841432\u20131437.","DOI":"10.1210\/jc.84.4.1432"},{"key":"2026070905570035900_NAKOPOULOU-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Nakopoulou\n            L\n          , Stefanaki K, Panayotopoulou E, Giannopoulou I, Athanassiadou P, Gakiopoulou-Givalou H & Louvrou A 2002 Expression of the vascular endothelial growth factor receptor-2\/Flk-1 in breast carcinomas: correlation with proliferation. Human Pathology33863\u2013870.","DOI":"10.1053\/hupa.2002.126879"},{"key":"2026070905570035900_NATHAN-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Nathan\n            CA\n          , Carter P, Liu L, Li BD, Abreo F, Tudor A, Zimmer SG & De Benedetti A 1997 Elevated expression of eIF4E and FGF-2 isoforms during vascularization of breast carcinomas. Oncogene151087\u20131094.","DOI":"10.1038\/sj.onc.1201272"},{"key":"2026070905570035900_NAUMOV-ETAL-2006","doi-asserted-by":"crossref","unstructured":"Naumov\n            GN\n          , Bender E, Zurakowski D, Kang SY, Sampson D, Flynn E, Watnick RS, Straume O, Akslen LA, Folkman J et al.2006 A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype.. Journal of the National Cancer Institue98316\u2013325.","DOI":"10.1093\/jnci\/djj068"},{"key":"2026070905570035900_NAVOLANIC-AND-MCCUBREY-2005","doi-asserted-by":"crossref","unstructured":"Navolanic\n            PM\n           & McCubrey JA 2005 Pharmacological breast cancer therapy (review). International Journal of Oncology271341\u20131344.","DOI":"10.3892\/ijo.27.5.1341"},{"key":"2026070905570035900_NEUFELD-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Neufeld\n            G\n          , Cohen T, Gengrinovitch S & Poltorak Z 1999 Vascular endothelial growth factor (VEGF) and its receptors. FASEB Journal139\u201322.","DOI":"10.1096\/fasebj.13.1.9"},{"key":"2026070905570035900_NICHOLSON-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Nicholson\n            RI\n          , Hutcheson IR, Hiscox SE, Knowlden JM, Giles M, Barrow D & Gee JMW 2005 Growth factor signaling and resistance to selective oestrogen receptor modulators and pure anti-oestrogens: the use of anti-growth factor therapies to treat or delay endocrine resistance in breast cancer. Endocrine-Related Cancer12S29\u2013S36.","DOI":"10.1677\/erc.1.00991"},{"key":"2026070905570035900_NICOSIA-AND-VILLASCHI-1999","doi-asserted-by":"crossref","unstructured":"Nicosia\n            RR\n           & Villaschi S 1999 Autoregulation of angio-genesis by cells of the vessel wall. International Reviews of Cytology1851\u201343.","DOI":"10.1016\/S0074-7696(08)60148-5"},{"key":"2026070905570035900_NOH-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Noh\n            JJ\n          , Maskarinec G, Pagano I, Cheung LW & Stanchyk FZ 2005 Mammographic densities and circulating hormones: a cross-sectional study in premenopausal women. Breast In Press.","DOI":"10.1016\/j.breast.2005.04.014"},{"key":"2026070905570035900_ORTEGA-ETAL-1999","unstructured":"Ortega\n            N\n          , Hutchings H & Plouet J 1999 Signal relays in the VEGF system. Frontiers of Bioscience4141\u2013152."},{"key":"2026070905570035900_OTSUKI-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Otsuki\n            M\n          , Saito H, Xu X, Sumitani S, Souhara H, Kishimoto T & Kasayama S 2001 Progesterone, but not medroxyprogesterone, inhibits vascular cell adhesion vascular cell adhesion molecule-1 expression in human vascular endothelial cells. Arteriosclerosis Thrombosis and Vascular Biology21243\u2013248.","DOI":"10.1161\/01.ATV.21.2.243"},{"key":"2026070905570035900_PAGES-AND-POUYSSEGUR-2005","doi-asserted-by":"crossref","unstructured":"Pages\n            G\n           & Pouyssegur J 2005 Transcriptional regulation of the vascular endothelial growth factor gene\u2014a concert of activating factors. Cardiovascular Research65564\u2013573.","DOI":"10.1016\/j.cardiores.2004.09.032"},{"key":"2026070905570035900_PAL-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Pal\n            S\n          , Claffey KP, Cohen HT & Mukhopadhyay D 1998 Activation of Sp1-mediated vascular permeability factor\/vascular endothelial growth factor transcription requires specific interaction with protein kinase C zeta. Journal of Biological Chemistry27326277\u201326280.","DOI":"10.1074\/jbc.273.41.26277"},{"key":"2026070905570035900_PAL-ETAL-2001","unstructured":"Pal\n            S\n          , Datta K & Mukhopadhyay D 2001 Central role of p53 on regulation of vascular permeability factor\/ vascular endothelial growth factor (VPF\/VEGF) expression in mammary carcinoma. Cancer Research616952\u20136957."},{"key":"2026070905570035900_PASQUALINI-2000","unstructured":"Pasqualini\n            JR\n          \n          2000 In Breast Cancer: Prognosis, Treatment and Prevention. New York: Marcel Dekker."},{"key":"2026070905570035900_PEKALA-ETAL-1990","doi-asserted-by":"crossref","unstructured":"Pekala\n            P\n          , Marlow M, Heuvelman D & Connolly D 1990 Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-alpha, but not by insulin. Journal of Biological Chemistry26518051\u201318054.","DOI":"10.1016\/S0021-9258(17)44710-7"},{"key":"2026070905570035900_PRICE-ETAL-2001","unstructured":"Price\n            DJ\n          , Miralem T, Jiang S, Steinberg R & Avraham H 2001 Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells. Cell Growth and Differentiation12129\u2013135."},{"key":"2026070905570035900_RAFII-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Rafii\n            S\n          , Lyden D, Benezra R, Hattori K & Heissig B 2002 Vascular and hematopoietic stem cells: novel targets for anti-angiogenesis therapy? Nature Reviews Cancer2826\u2013835.","DOI":"10.1038\/nrc925"},{"key":"2026070905570035900_RAGAZ-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Ragaz\n            J\n          , Miller K, Badve S, Dayachko Y, Dunn S, Nielsen T, Brodie A, Huntsman D, Bajdik C et al.2004 Adverse association of expressed vascular endothelial growth factor (VEGF) Her2, Cox2, uPA, and EMSY with long-term outcome of stage I\u2014III breast cancer (BrCA). Results from the British Columbia Tissue Microarray Project. Proceedings of the American Society of Clinical Oncology238.","DOI":"10.1200\/jco.2004.22.90140.524"},{"key":"2026070905570035900_RAK-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Rak\n            J\n          , Filmus J, Finkenzeller G, Grugel S, Marme D & Kerbel RS 1995 Oncogenes as inducers of tumor angiogenesis. Cancer Metastasis Review14263\u2013277.","DOI":"10.1007\/BF00690598"},{"key":"2026070905570035900_RAK-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Rak\n            J\n          , Filmus J & Kerbel RS 1996 Reciprocal paracrine interactions between tumor cells and endothelial cells: the \u2018angiogenesis progression\u2019 hypothesis. European Journal of Cancer322438\u20132450.","DOI":"10.1016\/S0959-8049(96)00396-6"},{"key":"2026070905570035900_RELF-ETAL-1997","unstructured":"Relf\n            M\n          , LeJeune S, Scott PA, Fox S, Smith K, Lee R, Moghaddam A, Whitehouse R, Bicknell R & Harris AL 1997 Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placental growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Research57963\u2013969."},{"key":"2026070905570035900_REOME-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Reome\n            JB\n          , Hylind JC, Dutton RW & Dobrazanski MJ 2004 Type 1 and type 2 tumor infiltrating effector cell subpopulations in progressive breast cancer. Clinical Immunology11169\u201381.","DOI":"10.1016\/j.clim.2003.11.013"},{"key":"2026070905570035900_REYNOLDS-ETAL-1992","doi-asserted-by":"crossref","unstructured":"Reynolds\n            LP\n          , Killilea SD & Redmer DA 1992 Angiogenesis in the female reproductive system. FASEB Journal6886\u2013892.","DOI":"10.1096\/fasebj.6.3.1371260"},{"key":"2026070905570035900_RIBATTI-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Ribatti\n            D\n          , Nico B, Vacca A, Roncali L & Dammacco F 2002 Endothelial cell heterogeneity and organ specificity. Journal of Hematotherapy and Stem Cell Research1181\u201390.","DOI":"10.1089\/152581602753448559"},{"key":"2026070905570035900_RISAU-1997","unstructured":"Risau\n            W\n          \n          1997 Mechanisms of angiogenesis. Nature386671\u2013674."},{"key":"2026070905570035900_ROBERTS-AND-PALADE-1995","doi-asserted-by":"crossref","unstructured":"Roberts\n            WG\n           & Palade GE 1995 Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. Journal of Cellular Sciences1082369\u20132379.","DOI":"10.1242\/jcs.108.6.2369"},{"key":"2026070905570035900_ROSS-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Ross\n            RK\n          , Paganini-Hill A, Wan PC & Pike MC 2000 Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. Journal of the National Cancer Institute92328\u2013332.","DOI":"10.1097\/00006254-200007000-00022"},{"key":"2026070905570035900_RUHOLA-ETAL-1999","unstructured":"Ruhola\n            JK\n          , Valve EM, Karkkainen MJ, Joukov V, Alitalo K & Harkonene PL 1999 Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells. Molecular and Cellular Endocrinology14929\u201340."},{"key":"2026070905570035900_RYDEN-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Ryden\n            L\n          , Linderholm B, Nielsen NH, Erndin S, Jonsson PE & Landberg G 2003 Tumor specific VEGF-A and VEGF2\/KDR protein are co-expressed in breast cancer. Breast Cancer Research and Treatment82147\u2013154.","DOI":"10.1023\/B:BREA.0000004357.92232.cb"},{"key":"2026070905570035900_RYDEN-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Ryden\n            L\n          , Jirstrom K, Bendahl PO, Ferno M, Nordenskjold B, Stal O, Thorstenson S, Jonsson PE & Landberg G 2005 Tumor specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premeopausal women. Journal of Clinical Oncology234695\u20134704.","DOI":"10.1200\/JCO.2005.08.126"},{"key":"2026070905570035900_SAARISTO-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Saaristo\n            A\n          , Karpanen T & Alitalo K 2000 Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis. Oncogene196122\u20136129.","DOI":"10.1038\/sj.onc.1203969"},{"key":"2026070905570035900_SARTORIUS-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Sartorius\n            CA\n          , Shen T & Horwitz KB 2003 Progesterone receptors A and B differentially affect the growth of estrogen-dependent human breast tumor xenografts. Breast Cancer Research and Treatment79287\u2013299.","DOI":"10.1023\/A:1024031731269"},{"key":"2026070905570035900_SCHAIRER-2002","doi-asserted-by":"crossref","unstructured":"Schairer\n            C\n          \n          2002 Progesterone receptors\u2014animal models and cell signaling in breast cancer, implications for breast cancer of inclusion of progestins in hormone replacement therapies. Breast Cancer Research4244\u2013248.","DOI":"10.1186\/bcr540"},{"key":"2026070905570035900_SCHNEIDER-AND-MILLER-2005","unstructured":"Schneider\n            BP\n           & Miller KD 2005 Angiogenesis of breast cancer. Journal of Clinical Oncology231782\u20131790."},{"key":"2026070905570035900_SCHOEFFNER-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Schoeffner\n            DJ\n          , Matheny SL, Akahane T, Factor V, Berry A, Merlino G & Thorgeirsson UP 2005 VEGF contributes to mammary tumor growth in transgenic mice through paracrine and autocrine mechanisms. Laboratory Investigation85608\u2013623.","DOI":"10.1038\/labinvest.3700258"},{"key":"2026070905570035900_SENGUPTA-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Sengupta\n            K\n          , Banerjee S, Saxena H & Banerjee SK 2003 Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway. International Journal of Oncology22609\u2013614.","DOI":"10.3892\/ijo.22.3.609"},{"key":"2026070905570035900_SHAO-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Shao\n            ZM\n          , Radziszewski WJ & Barsky SH 2000 Tamoxifen enhances myoepithelial cell suppression of human breast carcinoma progression in vitro by two different effector mechanisms. Cancer Letters157133\u2013144.","DOI":"10.1016\/S0304-3835(00)00466-3"},{"key":"2026070905570035900_SHI-ETAL-2001","unstructured":"Shi\n            HY\n          , Zhang W, Liang R, Abraham S, Kittrell FS, Medina D & Zhang M 2001 Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model. Cancer Research616945\u20136951."},{"key":"2026070905570035900_SHIRAKAWA-ETAL-2002A","doi-asserted-by":"crossref","unstructured":"Shirakawa\n            K\n          , Furuhata S, Watanabe I, Hayase H, Shimizu A, Ikarashi Y, Yoshida T, Terada M, Hashimoto D et al.2002a Induction of vasculogenesis in breast cancer models. British Journal of Cancer871454\u20131461.","DOI":"10.1038\/sj.bjc.6600610"},{"key":"2026070905570035900_SHIRAKAWA-ETAL-2002B","doi-asserted-by":"crossref","unstructured":"Shirakawa\n            K\n          , Shibuya M, Heike Y, Takashima S, Watanabe I, Konishi F, Kasumi F, Goldman CK, Thomas KA, Bett A 2002b Tumor-infiltrating endothelial cells and endothelial precursor cells in inflammatory breast cancer. International Journal of Cancer99344\u2013351.","DOI":"10.1002\/ijc.10336"},{"key":"2026070905570035900_SIMANTOV-AND-SILVERSTEIN-2003","doi-asserted-by":"crossref","unstructured":"Simantov\n            R\n           & Silverstein RL 2003 CD36: a critical anti-angiogenic receptor. Frontiers in Bioscience8S874\u2013S882.","DOI":"10.2741\/1168"},{"key":"2026070905570035900_SLEDGE-JR-AND-MILLER-2003","unstructured":"Sledge\n            GW\n           Jr & Miller KD 2003 Exploiting the hallmarks of cancer: the future conquest of breast cancer. European Journal of Cancer391668\u20131675."},{"key":"2026070905570035900_SODERQVIST-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Soderqvist\n            G\n          , Isaksson E, von Schoultz B, Carlstrom K, Tani E & Skoog L 1997 Proliferation of breast epithelial cells in healthy women during the menstrual cycle. American Journal of Obstetrics and Gynecology176123\u2013128.","DOI":"10.1016\/S0002-9378(97)80024-5"},{"key":"2026070905570035900_SORDELLO-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Sordello\n            S\n          , Bertrand N & Plouet J 1998 Vascular endothelial growth factor is up-regulated in vitro and in vivo by androgens. Biochemical and Biophysical Research Communications251287\u2013290.","DOI":"10.1006\/bbrc.1998.9328"},{"key":"2026070905570035900_SOUFLA-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Soufla\n            G\n          , Porchis R, Sourvinos G, Vassilaros S & Spandidos DA 2005 Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3, and cognate receptors in breast tumorigenesis. Cancer Letters In Press.","DOI":"10.1016\/j.canlet.2005.04.022"},{"key":"2026070905570035900_SPEIRS-AND-ATKIN-1999","doi-asserted-by":"crossref","unstructured":"Speirs\n            V\n           & Atkin SL 1999 Production of VEGF and expression of the VEGF receptors Flt-1 and KDR in primary cultures of epithelial and stromal cells derived from breast tumors. British Journal of Cancer80898\u2013903.","DOI":"10.1038\/sj.bjc.6690438"},{"key":"2026070905570035900_SPRING-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Spring\n            H\n          , Schuler T, Arnold B, Hammerling GJ & Ganss R 2005 Chemokines direct endothelial progenitors into tumor neovessels. PNAS10218111\u201318116.","DOI":"10.1073\/pnas.0507158102"},{"key":"2026070905570035900_STEVENS-ETAL-2003","unstructured":"Stevens\n            A\n          , Soden J, Brenchley PE, Ralph S & Ray DW 2003 Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Research63812\u2013816."},{"key":"2026070905570035900_STONER-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Stoner\n            M\n          , Wormke M, Saville B, Samudio I, Qin C, Abdelrahim M & Safe S 2004 Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins. Oncogene231052\u20131063.","DOI":"10.1038\/sj.onc.1207201"},{"key":"2026070905570035900_THOMAS-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Thomas\n            T\n          , Rhodin J, Clark L & Garces A 2003 Progestins initiate adverse events of menopausal estrogen therapy. Climacteric6265\u2013267.","DOI":"10.1080\/cmt.6.4.293.301"},{"key":"2026070905570035900_TOI-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Toi\n            M\n          , Hoshina S, Takayanagi T & Tominaga T 1994 Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Japanese Journal of Cancer Research851045\u20131049.","DOI":"10.1111\/j.1349-7006.1994.tb02904.x"},{"key":"2026070905570035900_TOI-ETAL-1995A","unstructured":"Toi\n            M\n          , Inada K, Hoshina S, Suzuki H, Kondo S & Tominaga T 1995a Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer. Clinical Cancer Research1961\u2013964."},{"key":"2026070905570035900_TOI-ETAL-1995B","doi-asserted-by":"crossref","unstructured":"Toi\n            M\n          , Inada K, Suzuki H & Tominaga T 1995b Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Research and Treatment36193\u2013204.","DOI":"10.1007\/BF00666040"},{"key":"2026070905570035900_UMEKITA-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Umekita\n            Y\n          , Ohi Y, Sagara Y & Yoshidat I 2002 Expression of maspin predicts poor prognosis in breast-cancer patients. International Journal of Cancer100452\u2013455.","DOI":"10.1002\/ijc.10500"},{"key":"2026070905570035900_URAY-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Uray\n            IP\n          , Liang Y & Hyder SM 2004 Estradiol down regulates CD36 expression in human breast cancer cells. Cancer Letters20101\u2013107.","DOI":"10.1016\/j.canlet.2003.10.021"},{"key":"2026070905570035900_WANG-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Wang\n            TN\n          , Qian XH, Granick MS, Soloman MP, Rothman VL, Berger DH & Tuszynski GP 1996 Inhibition of breast cancer progression by an antibody to thrombospondin-1 receptor. Surgery120449\u2013454.","DOI":"10.1016\/S0039-6060(96)80322-9"},{"key":"2026070905570035900_WEDAM-ETAL-2006","doi-asserted-by":"crossref","unstructured":"Wedam\n            SB\n          , Low JA, Yang SX, Chow CK, Choyke P, Danforth D, Hewitt SM, Berman A & Steinberg SM 2006 Antiangiogenic and antitumor effects of bevacizumab in inflammatory and locally advanced breast cancer patients. Journal of Clinical Oncology In Press.","DOI":"10.1200\/JCO.2005.03.4645"},{"key":"2026070905570035900_WEIDNER-ETAL-1991","doi-asserted-by":"crossref","unstructured":"Weidner\n            N\n          , Semple JP, Welch WR & Folkman J 1991 Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. New England Journal of Medicine3241\u20138.","DOI":"10.1056\/NEJM199101033240101"},{"key":"2026070905570035900_WEIDNER-ETAL-1992","doi-asserted-by":"crossref","unstructured":"Weidner\n            N\n          , Folkman J, Pozza F, Bevilacque P, Allred EN, More DH, Meli S & Gasparnini G 1992 Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. Journal of the National Institutes of Cancer841875\u20131887.","DOI":"10.1093\/jnci\/84.24.1875"},{"key":"2026070905570035900_WOOLARD-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Woolard\n            J\n          , Wang WY, Bevan HS, Qiu Y, Morbidelli L, Pritchard-Jones RO, Cui TG, Sugiono M, Waine E, Perrin R et al.2004 VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Research647822\u20137835.","DOI":"10.1158\/0008-5472.CAN-04-0934"},{"key":"2026070905570035900_WRITING-GROUP-FOR-WOMENHEALTH-2002","doi-asserted-by":"crossref","unstructured":"Writing Group for the Women\u2019s Health Initiative Investigators 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women\u2019s health initiative randomized controlled trial. Journal of the American Medical Association288321\u2013333.","DOI":"10.1001\/jama.288.3.321"},{"key":"2026070905570035900_WU-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Wu\n            J\n          , Richer J, Horwitz KB & Hyder SM 2004 Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B. Cancer Research642238\u20132244.","DOI":"10.1158\/0008-5472.CAN-03-3044"},{"key":"2026070905570035900_WU-ETAL-2005A","doi-asserted-by":"crossref","unstructured":"Wu\n            J\n          , Brandt S & Hyder SM 2005a Ligand- and cell-specific effects of signal transduction pathway inhibitors on progestin-induced vascular endothelial growth factor levels in human breast cancer cells. Molecular Endocrinology19312\u2013326.","DOI":"10.1210\/me.2004-0252"},{"key":"2026070905570035900_WU-ETAL-2005B","unstructured":"Wu\n            J\n          , Liang Y, Nawaz Z & Hyder SM 2005b Complex agonist-like properties of ICI 182,780 (Faslodex) in human breast cancer cells that predominantly express progesterone receptor-B: implications for treatment resistance. International Journal of Oncology271647\u20131659."},{"key":"2026070905570035900_YAMAMOTO-ETAL-1996","unstructured":"Yamamoto\n            Y\n          , Toi M, Kondo S, Matsumoto T, Suzuki H, Kitamura M, Tsuruta K, Taniguchi T, Okamoto A & Mori T 1996 Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clinical Cancer Research2821\u2013826."},{"key":"2026070905570035900_YAZIDI-ETAL-1998","unstructured":"Yazidi\n            IE\n          , Renaud F, Laurent M, Courtois Y & Boilly-Marer Y 1998 Production and estrogen regulation of FGF1 in normal and cancer breast cells. Biochimica Biophysica Acta1403127\u2013140."},{"key":"2026070905570035900_ZETTER-1998","unstructured":"Zetter\n            RR\n          \n          1998 Angiogenesis and tumor metastasis. Annual Reviews in Medicine49407\u2013424."},{"key":"2026070905570035900_ZHANG-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Zhang\n            HT\n          , Craft P, Scott PA, Ziche M, Weich HA, Harris AL & Bicknell R 1995 Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. Journal of the National Cancer Institute87213\u2013219.","DOI":"10.1093\/jnci\/87.3.213"},{"key":"2026070905570035900_ZHANG-ETAL-2000A","doi-asserted-by":"crossref","unstructured":"Zhang\n            HT\n          , Scott PA, Morbidelli L, Peak S, Moore J, Turley H, Harris AL, Ziche M & Bicknell R 2000a The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo. British Journal of Cancer8363\u201368.","DOI":"10.1054\/bjoc.2000.1279"},{"key":"2026070905570035900_ZHANG-ETAL-2000B","unstructured":"Zhang\n            M\n          , Volpert O, Shi YH, Peak S, Moor J, Turley H, Harris AL, Ziche M & Bicknell R 2000b Maspin is an angiogenesis inhibitor. Nature Medicine6196\u2013199."},{"key":"2026070905570035900_ZHANG-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Zhang\n            W\n          , Ran S, Sambade M, Huang X & Thorpe PE 2002 A monoclonal antibody that blocks VEGF binding to VEGFR2 (KDR\/Flk-1) inhibits vascular expression of Flk-1 and tumor growth in an orthotopic human breast cancer model. Angiogenesis535\u201344.","DOI":"10.1023\/A:1021540120521"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/13\/3\/0130667.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/13\/3\/667\/149919\/0130667.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/13\/3\/667\/149919\/0130667.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T09:57:42Z","timestamp":1783591062000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/13\/3\/667\/26682\/Sex-steroid-regulation-of-vascular-endothelial"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,1]]},"references-count":212,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9,1]]}},"URL":"https:\/\/doi.org\/10.1677\/erc.1.00931","relation":{},"ISSN":["1479-6821","1351-0088"],"issn-type":[{"value":"1479-6821","type":"electronic"},{"value":"1351-0088","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9,1]]}}}